IP Library Granted Patent US 10,383,909
Granted Patent B2
US 10,383,909 · App. 13/816,469 · Granted Aug 20, 2019

Use of a plant extract, pharmaceutical compositions and use thereof

Inventors: Avaniel Marinho Da Silva (Recife-PE, BR); Tulio Flavio Accioly Lima E Moura (Natal-RN, BR); Severno Barbosa Dos Santos (Recife-PE, BR)
Assignee: HEBRON FARMACEUTICA PESQUISA, DESENVOLVIMENTO E INOVACAO TECNOLOGICA LTDA
A61K36/77A61K36/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,383,909
App. No.
13/816,469
Granted
Aug 20, 2019
Kind
B2
Abstract

The present invention relates to the use of a plant extract obtained from at least one plant of the Anacardiaceae family, for the preparation of a pharmaceutical composition used as a new herbal medicine for the prophylaxis and/or treatment of disorders associated with the digestive tract, and the relief of symptoms associated with these disorders. Additionally, through the scope of the present invention, the substances isolated from said extract also consist of the active ingredients of pharmaceutical compositions. A third objective of the invention is the use of said pharmaceutical compositions in the preparation of the class of herbal medicines for the prophylaxis and/or treatment of disorders associated with the digestive tract, in different stages, with posology and daily dosing.

Claims (17)

1. A method for treating an H. pylori -effected disorder associated with the digestive tract comprising administering to a subject suffering therefrom an herbal medicine comprising an effective amount of a plant extract obtained from the species Schinus terebinthifolius , wherein the extract is obtained by an extraction reaction conducted with an organic solvent comprising alcohol and water, and wherein said extract of Schinus terebinthifolius is obtained from stem bark.

2. The method according to claim 1 , wherein the extract in the administered herbal medicine has a therapeutic activity on gastric mucosal lesions in the subject.

3. The method according to claim 2 , wherein the gastric mucosal lesions are selected from the group consisting of peptic ulcers, gastritis, gastropathy, peptic ulcer disease, inflammation, and duodenitis in different stages.

4. The method according to claim 1 , wherein said extract is Schinus terebinthifolius Raddi.

5. The method according to claim 1 , wherein the alcohol is selected from the group consisting of ethanol and methanol.

6. The method according to claim 5 , wherein the organic solvent is ethanol and the extract is obtained at a reaction temperature between about 50° C. to about 100° C. for a period of development of the reaction from approximately 20 to 50 minutes.

7. The method according to claim 6 , wherein the reaction temperature is approximately 70° C. for a period of about 30 minutes and the extract is dried by a method selected from the group consisting of spray drying and lyophilization.

8. The method according to claim 1 , wherein said herbal medicine is administered orally.

9. The method according to claim 8 , wherein the herbal medicine is in a form selected from the group consisting of tablets, pills, capsules, solutions and suspensions.

10. The method according to claim 9 , wherein the herbal medicine form is a tablet.

11. The method according to claim 10 , wherein said tablet is a coated tablet.

12. The method according to claim 11 , wherein the tablet comprises at least one coated layer formed by a cellulosic polymer.

13. The method according to claim 12 , wherein the tablet has a total mass of 233.60 mg, consisting of a hydroalcoholic extract of S. terebinthifolius , microcrystalline cellulose, croscarmellose sodium and magnesium stearate.

14. The method according to claim 13 , wherein the tablet comprises approximately 6.00 mL to about 10.00 mL of said hydroalcoholic extract.

15. The method according to claim 14 , wherein said tablet comprises from about 7.00 mL to about 9.00 mL of said hydroalcoholic extract.

16. The method according to claim 14 , wherein said tablet comprises about 8.207 mL of said hydroalcoholic extract of S. terebinthifolius.

17. The method according to claim 10 , wherein 1 to 4 of said tablets are administered to the subject per day.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 28, 2013
From: DA SILVA, AVANIEL MARINHO; DE LIMA E MOURA, TULIO FLAVIO ACCIOLY; DOS SANTOS, SEVERINO BARBOSA
To: HEBRON FARMACEUTICA PESQUISA, DESENVOLVIMENTO E INOVACAO TECNOLOGICA LTDA
Reel/Frame 030493/0915 →
Priority Claims (1)
BR PI1002720-3 · Aug 11, 2010 · national
Continuity (1)
Related Publication 20130302419A1 · Nov 14, 2013